Aspen Pharmacare (APN/ZAC) Stock Forecast for 2026, 2030-2040

December 2026 9.96%
ZAC 19,269
January 2027 4.47%
ZAC 18,308
February 2027 27.7%
ZAC 22,378
March 2027 22.14%
ZAC 21,404
April 2027 51.31%
ZAC 26,515
May 2027 51.99%
ZAC 26,634
June 2027 57.81%
ZAC 27,654
July 2027 62.15%
ZAC 28,415
August 2027 78.5%
ZAC 31,280
September 2027 65.17%
ZAC 28,944
October 2027 75.17%
ZAC 30,696
November 2027 78.09%
ZAC 31,209
Current price: ZAC 17,524 24 0.14%
Real-time Data 11:08
Daily range 17447 Arrow from to Icon 17608
Weekly range 17300 Arrow from to Icon 18142
Loading...
Month Minimum Price Maximum Price Average Price
December 2026 ZAC 18,884 ZAC 19,654 ZAC 19,269
January 2027 ZAC 17,942 ZAC 18,674 ZAC 18,308
February 2027 ZAC 21,930 ZAC 22,826 ZAC 22,378
March 2027 ZAC 20,976 ZAC 21,832 ZAC 21,404
April 2027 ZAC 25,985 ZAC 27,045 ZAC 26,515
May 2027 ZAC 26,101 ZAC 27,167 ZAC 26,634
June 2027 ZAC 27,101 ZAC 28,207 ZAC 27,654
July 2027 ZAC 27,847 ZAC 28,983 ZAC 28,415
August 2027 ZAC 30,654 ZAC 31,906 ZAC 31,280
September 2027 ZAC 28,365 ZAC 29,523 ZAC 28,944
October 2027 ZAC 30,082 ZAC 31,310 ZAC 30,696
November 2027 ZAC 30,585 ZAC 31,833 ZAC 31,209

Technical Outlook

Neutral

Overall signal across
25 indicators

  • Moving Averages
    Buy 0
    Sell 0
  • Indicators
    Buy 0
    Sell 0
  • Timeframe

Aspen Pharmacare Analyst Consensus Forecast

Overall Consensus
Buy
Updated: Oct 15, 2026
Trade Stocks with SpeedTrader
Your capital is at risk.
Avg. Price Target (6M)
ZAC 17.3K -1.5%
Price Range Target (6M)
ZAC 16.5K Lowest
ZAC 18.3K Highest
Ratings Distribution
Strong Buy
4
Buy
6
Hold
5
Sell
0
Strong Sell
0
Sentiment Score
7.3 /10
Positive

All figures in this block are based on aggregated analyst consensus data from a broad set of market participants. Analyst ratings, when available, show recent updates only and may not represent the full set of analysts behind the consensus.

Popular Forecasts in United States

1-year forecasts for popular assets in United States

Aspen Pharmacare Price Forecast for 2026, 2030, 2040

Year Price in the middle of the year Price at the end of the year
2028 ZAC 42,536 ZAC 49,793
2029 ZAC 38,976 ZAC 39,460
2030 ZAC 38,140 ZAC 35,490
2031 ZAC 18,530 ZAC 13,806
2032 ZAC 16,386 ZAC 19,724
2033 ZAC 17,231 ZAC 22,278
2034 ZAC 30,849 ZAC 19,113
2035 ZAC 18,736 ZAC 25,234
2036 ZAC 27,968 ZAC 32,069
2037 ZAC 22,656 ZAC 16,424
2038 ZAC 16,055 ZAC 21,562
2039 ZAC 25,517 ZAC 28,382
2040 ZAC 38,553 ZAC 34,185

How our forecasts work

Based on data from 10+ trusted market providers
Built using technical indicators and statistical models
Regularly updated to reflect changing market conditions
Reviewed by the TU analytical team under the Methodology

Best Place to Trade Stocks

Investment Return Calculator

Return Calculator (Historical)
ROI RESULT
 
 
ROI shows how effectively your investment performed — how much profit or loss it generated over the selected period.
Chief Analytics Officer

Anton Kharitonov, Chief Analytics Officer at TU, oversees the Methodology and quality control processes behind TU’s financial forecasts. TU forecasts are based on proprietary analytical models that review market history, technical indicators, volatility, and trend data across different timeframes. The TU analytics team regularly monitors the Methodology and checks forecast quality using data from trusted market providers.

What is your APN price forecast for 2030?
Vote to see the results!
Uptrend
Downtrend

This forecast reflects the audience’s market expectations regarding the asset’s price direction by 2030. The data is automatically updated as new votes come in, providing a dynamic snapshot of overall market sentiment.

FAQs

  • What is the Aspen Pharmacare (APN) forecast by the end of 2026?

    Our projections suggest that by the end of 2026, Aspen Pharmacare’s share price could fluctuate between ZAC 18,884 and ZAC 19,654, with an average estimate near ZAC 19,269. These scenarios are based on historical performance, valuation models, and expected earnings growth.

  • What is the forecasted price of Aspen Pharmacare (APN) in 2031?

    According to our statistical model, the average projected price of Aspen Pharmacare stock in 2031 could be around ZAC 18,530 by mid-year and approximately ZAC 13,806 by year-end. Actual results may differ based on innovation cycles, global demand, and corporate profitability.

  • How much will Aspen Pharmacare (APN) be worth in 10 years?

    Based on long-term statistical projections, Aspen Pharmacare’s stock could average around ZAC 32,069 by the end of 2036. Actual outcomes may vary depending on future technological developments, revenue growth, and global market conditions.

  • What factors are used to calculate long-term Aspen Pharmacare (APN) price predictions?

    Long-term Aspen Pharmacare (APN) price predictions are based on historical share price data ranging from several months to the full available price history. The models combine long-term statistical forecasting models, historical price patterns, trend analysis, long-term market behavior, and key fundamental factors, including Aspen Pharmacare stock earnings growth, financial performance, valuation metrics, and broader economic conditions.

  • How often are long-term APN forecasts updated?

    APN forecasts for the next year are reviewed and recalculated daily. Forecasts with horizons longer than one year are reviewed and updated weekly.

  • Can long-term APN forecasts guarantee future prices?

    No. Long-term APN forecasts represent price scenarios based on historical data and statistical models. Actual share prices may differ significantly due to unexpected changes in the company`s financial performance, earnings results, product launches, competitive conditions, macroeconomic developments, regulatory actions, or overall market sentiment. In general, the longer the forecast horizon, the more unpredictable factors may influence future APN share prices.

People Also Watch Prediction:

Disclaimer

All information on the pages containing forecasts, video forecasts, and other analytical materials is published ‘as is’ and for informational purposes only. The information is not intended for trading or advice of financial, investment, tax, legal, accounting or any kind of nature. Before starting to trade, please contact your broker or a financial advisor to check the quotes, evaluate forecasts or the opinion of the author of the article. Our company is not an investment consultant, financial advisor or a broker for transactions involving securities. No information shall be viewed as investment advice, recommendation or offer of our company to buy, hold or sell securities or financial products. Our company does not provide guarantees and does not express opinions about appropriateness or suitability of investments.

No information shall be regarded as investment advice (general or individual). Financial products or transactions mentioned in such information may not be suitable for your investment portfolio and may not meet your investment targets and expectations. You are solely responsible for any decision regarding financial products or transactions and you shall independently determine whether they are suitable for you, taking into account your interests, investment targets, investment horizon and tolerable risk level. Our company shall not bear any responsibility for the losses caused by financial transactions or investments in financial products mentioned on our website. We do not recommend making investment decisions guided solely by this information.

The information on our website is provided by stock exchanges, brokers and other content providers, and, in some cases, may arrive with a delay. Our company does not verify such information and shall waive any liability related to it.

Our company and our information and content providers, financial exchanges, brokers and also all affiliated companies and business partners: a) expressly waive any responsibility for the accuracy, validity and completeness of any data; b) shall not be liable for any mistakes, omissions or other flaws on such information, for delays and interruptions in their display, as well as for actions taken based on such information. Neither our company nor our information providers shall be liable for the damage caused by the use of the information provided here. The term ‘business partners’ in this case shall not imply any partnership or agency relationships as well as the creation of a joint venture between our company and any other organization.

You hereby confirm that you shall not copy, modify, reformat, download, store, reproduce, process, transfer or distribute any information published here or use such information for commercial purposes without prior written consent.

Traders Union as well as its external information and content providers retain exclusive copyright to the provided information.

Our company shall not be liable for the products and services advertised on our website.

General websites Disclaimer:

Traders Union (tradersunion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it. Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit.

That is why you should only invest money you are willing and able to lose, given the high level of risk involved. Tradersunion.com does not offer financial services, including investment or financial advisory services. Traders Union is not a broker and does not receive compensation for trading in the Forex or CFD markets. Our website only provides informational content about brokers and financial markets and helps users choose the most suitable brokerage company based on comprehensive data and objective analysis..

Price Analysis and Forecasting Methodology

Traders Union applies a proprietary, multi-layered methodology for forecasting prices of currencies, cryptocurrencies, stocks, indices, and commodities. It combines technical indicators, statistical modeling, expert insights, and on-chain metrics. The analysis is based on data sourced from trusted third-party providers, including Twelve Data, Financial Modeling Prep, Polygon.io, CoinMarketCap, and leading cryptocurrency exchanges such as Binance, Bybit, OKX, and MEXC.